3-Year Innovation Project is Completed

3-year innovation project with the Danish Life Science Cluster is completed with the Brain+ CST-Therapist Companion product as the final output A 3-year collaboration project between VIA University College, MedTech Innovation Consortium (MTIC), and Brain+ […]

Caroline Grube-Nagel   Brain+ Blog
DETAIL

Strong Q4 with Product Launch & Successful Capital Raise

Brain+ announces Investor Webinar  following strong Q4 with product launch and succesful capital raise Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful […]

Caroline Grube-Nagel   Brain+ Blog
DETAIL

WHO points to CST to solve the dementia burden

A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia […]

Caroline Grube-Nagel   Brain+ Blog
DETAIL

CST Therapist Companion advancing

Brain+ further advances its first digital dementia product, Cognitive Stimulation Therapy (CST) – Therapist Companion Commercial launch in Denmark will be November 1, 2022 Adaptation of a UK product version for the United Kingdom starts […]

DETAIL

Brain+ begins early activity and brand building in the US

Brain+ begins early activity and brand building in the US The United States (US) is a key future market for Brain+, and early brand building and exploration is now ongoing Brain+ has been selected and […]

DETAIL

Brain+’ new product for dementia launching Q4 2022

  Brain+’ new product for dementia launching Q4 2022     Digital “CST–Therapist Companion” is launching one year ahead of plan   The Brain+ “CST-Therapist Companion” is a new digital product to deliver Cognitive Stimulation Therapy […]

DETAIL

Germany opens the DiPA reimbursement pathway

Germany opens the DiPA reimbursement pathway to support the adoption of digital health applications, underpinning the value of the #1 target market for Brain+’ first commercial dementia product, CST A significant event for Brain+ as […]

DETAIL